Dr. Martens is no longer for sale. R. Griggs, which owns the brand, said that it ended talks after offers failed to reflect what was deemed to be a fair value for the operation. The company had been considering a sale since the beginning of the year, when it hired Rothschild Trust Holding as financial advisers to follow it up. Recently, speculation was rife about a bid by the Russian tycoon Mikhail Fridman via his investment fund Pamplona Capital, with an offer ranging around £200 million (€252.6m-$312.6m), almost double the brand's turnover of £126 million (€159.1m-$196.9m) for the fiscal year ended on March 31 and almost nine times the Ebitda of £22.6 million (€28.5m-$35.3m), 20 percent higher than the previous year. Just days before the announcement that plans for a sale had been shelved, the online fashion retailer Asos reported a 230 percent rise in sales of Dr. Martens boots from 2011 to 2012, an element that might have convinced Dr. Martens' owners to change their minds. The outlook for Dr. Martens this year is for revenues to go up between 20 percent and 30 percent, with plans for 30 new store openings throughout the period.